Variant report

Variant	esv1819475
Chromosome Location	chr21:44820999-44837533
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:58)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:3)

No data

(count:58 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr21:44818567..44821286-chr21:44833722..44837322,3	MCF-7	breast:
2	chr21:44829086..44831055-chr21:44919731..44921283,2	MCF-7	breast:
3	chr21:44751981..44753821-chr21:44820405..44821935,2	MCF-7	breast:
4	chr21:44820781..44823244-chr21:44845092..44848273,4	K562	blood:
5	chr21:44815638..44818048-chr21:44819779..44823056,3	MCF-7	breast:
6	chr21:44818567..44821286-chr21:44833722..44837322,3	MCF-7	breast:
7	chr21:44595506..44597559-chr21:44837131..44839693,2	MCF-7	breast:
8	chr10:59675342..59676099-chr21:44834961..44835685,2	Hela-S3	cervix:
9	chr21:44595496..44597017-chr21:44829022..44831353,2	MCF-7	breast:
10	chr21:44759532..44761977-chr21:44827634..44830066,2	MCF-7	breast:
11	chr21:44826742..44829631-chr21:44845519..44848403,3	K562	blood:
12	chr21:44760953..44765969-chr21:44827582..44835473,8	MCF-7	breast:
13	chr21:44821621..44823244-chr21:44846507..44848273,2	K562	blood:
14	chr21:44762766..44765210-chr21:44829593..44833216,5	MCF-7	breast:
15	chr21:44818100..44821352-chr21:44920857..44923649,3	MCF-7	breast:
16	chr21:44829643..44831600-chr21:44834056..44835815,3	MCF-7	breast:
17	chr21:44818474..44821317-chr21:44840540..44842574,2	K562	blood:
18	chr21:44826966..44831025-chr21:44834316..44837805,5	K562	blood:
19	chr11:82997053..82997597-chr21:44836794..44837527,2	Hela-S3	cervix:
20	chr21:44817995..44818827-chr21:44829450..44830022,2	MCF-7	breast:
21	chr21:44818715..44822400-chr21:44825874..44830059,6	MCF-7	breast:
22	chr21:44810332..44812959-chr21:44829398..44831869,3	MCF-7	breast:
23	chr21:44823778..44826577-chr21:44921300..44923032,2	MCF-7	breast:
24	chr21:44825113..44826687-chr21:44829541..44831627,2	K562	blood:
25	chr21:44762784..44765751-chr21:44820003..44823083,3	MCF-7	breast:
26	chr21:44825113..44826687-chr21:44829541..44831627,2	K562	blood:
27	chr10:102820540..102821482-chr21:44836170..44837079,2	Hela-S3	cervix:
28	chr21:44823951..44826613-chr21:44829582..44832057,3	K562	blood:
29	chr21:44818494..44821466-chr21:44822978..44824850,3	MCF-7	breast:
30	chr11:66845412..66846012-chr21:44835009..44836001,2	Hela-S3	cervix:
31	chr21:44829643..44831600-chr21:44834056..44835815,3	MCF-7	breast:
32	chr21:44826966..44831025-chr21:44834316..44837805,5	K562	blood:
33	chr21:44816513..44819832-chr21:44823325..44826638,3	MCF-7	breast:
34	chr21:44823951..44826613-chr21:44829582..44832057,3	K562	blood:
35	chr13:99738994..99739700-chr21:44835814..44836575,2	Hela-S3	cervix:
36	chr21:44824614..44826616-chr21:44827888..44829786,2	MCF-7	breast:
37	chr21:44814731..44816926-chr21:44832531..44834607,2	MCF-7	breast:
38	chr21:44835215..44837939-chr21:44907787..44909882,2	MCF-7	breast:
39	chr21:44829431..44829955-chr21:44849916..44850639,2	MCF-7	breast:
40	chr21:44762637..44765134-chr21:44833534..44838012,6	MCF-7	breast:
41	chr21:44818494..44821466-chr21:44822978..44824850,3	MCF-7	breast:
42	chr21:44815903..44818451-chr21:44831220..44833651,3	MCF-7	breast:
43	chr21:44829762..44832356-chr21:44845414..44847216,3	K562	blood:
44	chr21:44834200..44834810-chr5:65017885..65018593,2	Hela-S3	cervix:
45	chr21:44818343..44820016-chr21:44828957..44830875,2	MCF-7	breast:
46	chr21:44833113..44833867-chr6:12008935..12009469,2	Hela-S3	cervix:
47	chr21:44826611..44829527-chr21:44923973..44926200,2	MCF-7	breast:
48	chr21:44835183..44837638-chr21:45079405..45081633,2	K562	blood:
49	chr21:44815060..44818053-chr21:44827899..44829488,2	MCF-7	breast:
50	chr21:44393742..44396489-chr21:44837195..44839008,3	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CRYAA-3	chr21:44821458-44821739	XLOC_013962

No data

(count:3 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	SIK1	hsa-miR-32-5p	chr21:44835772-44835765
2	SIK1	hsa-miR-32-5p	chr21:44835766-44835791
3	SIK1	hsa-miR-32-5p	chr21:44834567-44834561

Variant related genes	Relation type
ENSG00000237864	chromatin interactions
ENSG00000142178	chromatin interactions
ENSG00000137500	chromatin interactions
ENSG00000160208	chromatin interactions
ENSG00000197860	chromatin interactions
ENSG00000255234	chromatin interactions
ENSG00000123213	chromatin interactions
ENSG00000095951	chromatin interactions
ENSG00000270022	chromatin interactions
ENSG00000160199	chromatin interactions
ENSG00000273162	chromatin interactions

Extended variants
information (count: 938 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:938 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs531507141	chr21:44821034-44821035	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs551944129	chr21:44821042-44821043	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs115761441	chr21:44821057-44821058	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs180946492	chr21:44821058-44821059	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs529435863	chr21:44821069-44821070	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs368011510	chr21:44821104-44821105	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs370087474	chr21:44821112-44821113	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs184586628	chr21:44821125-44821126	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs539460196	chr21:44821126-44821127	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs371912045	chr21:44821155-44821156	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs552022323	chr21:44821164-44821165	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs535131454	chr21:44821212-44821213	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs570267390	chr21:44821216-44821217	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs537232415	chr21:44821224-44821225	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs558015208	chr21:44821245-44821246	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs553354816	chr21:44821312-44821313	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs536645218	chr21:44821313-44821314	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs73380242	chr21:44821329-44821330	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs535212048	chr21:44821331-44821332	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs553592519	chr21:44821332-44821333	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs557254120	chr21:44821334-44821335	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs372676989	chr21:44821363-44821364	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs73906532	chr21:44821381-44821382	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs564373163	chr21:44821403-44821404	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs576440434	chr21:44821424-44821425	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs189505860	chr21:44821451-44821452	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs17004544	chr21:44821455-44821456	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs149894570	chr21:44821463-44821464	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs559597001	chr21:44821504-44821505	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs368626216	chr21:44821507-44821508	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
31	rs551517004	chr21:44821525-44821526	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs73223009	chr21:44821534-44821535	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs7279625	chr21:44821546-44821547	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs369624234	chr21:44821561-44821562	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs549156634	chr21:44821578-44821579	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs73380248	chr21:44821630-44821631	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs534890335	chr21:44821659-44821660	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs553804711	chr21:44821663-44821664	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs373091052	chr21:44821668-44821669	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs565654211	chr21:44821670-44821671	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs73906535	chr21:44821671-44821672	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs73380250	chr21:44821672-44821673	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs576405169	chr21:44821777-44821778	Enhancers Weak transcription Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs570640614	chr21:44821804-44821805	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs543783095	chr21:44821844-44821845	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs762388	chr21:44821867-44821868	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs573835204	chr21:44821875-44821876	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs57145743	chr21:44821881-44821882	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs559779754	chr21:44821959-44821960	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs533292213	chr21:44821966-44821967	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:825 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:44790600-44830800	Weak transcription	Right Atrium	heart
2	chr21:44808600-44823000	Weak transcription	Brain Germinal Matrix	brain
3	chr21:44814000-44822400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr21:44814400-44822000	Enhancers	Placenta	Placenta
5	chr21:44814800-44822200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
6	chr21:44816200-44821600	Weak transcription	Lung	lung
7	chr21:44816200-44822800	Enhancers	Spleen	Spleen
8	chr21:44816400-44823200	Enhancers	Fetal Muscle Leg	muscle
9	chr21:44816800-44823000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr21:44817000-44822400	Enhancers	Adipose Nuclei	Adipose
11	chr21:44817000-44823200	Enhancers	Primary hematopoietic stem cells	blood
12	chr21:44817400-44821400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr21:44817400-44821400	Enhancers	Rectal Mucosa Donor 29	rectum
14	chr21:44817400-44821800	Enhancers	Duodenum Mucosa	Duodenum
15	chr21:44817600-44821000	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr21:44817600-44821600	Weak transcription	HUES6 Cell Line	embryonic stem cell
17	chr21:44817600-44823600	Enhancers	HepG2	liver
18	chr21:44817600-44829200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr21:44817800-44823200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
20	chr21:44818000-44823200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr21:44818000-44823600	Weak transcription	Fetal Intestine Large	intestine
22	chr21:44818200-44822200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr21:44818400-44821000	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
24	chr21:44818600-44821400	Weak transcription	Fetal Kidney	kidney
25	chr21:44818800-44822400	Weak transcription	Esophagus	oesophagus
26	chr21:44819000-44822400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr21:44819200-44822400	Enhancers	Dnd41	blood
28	chr21:44819200-44823200	Weak transcription	Gastric	stomach
29	chr21:44819400-44821200	Enhancers	Colonic Mucosa	Colon
30	chr21:44819400-44822400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
31	chr21:44819400-44824200	Enhancers	Primary B cells from cord blood	blood
32	chr21:44819600-44821000	Enhancers	Stomach Mucosa	stomach
33	chr21:44819600-44821800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr21:44819600-44822200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr21:44819800-44822000	Enhancers	Fetal Lung	lung
36	chr21:44819800-44822400	Enhancers	Primary T helper cells PMA-I stimulated	--
37	chr21:44820000-44822000	Enhancers	Primary T cells fromperipheralblood	blood
38	chr21:44820000-44822200	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
39	chr21:44820000-44822200	Bivalent Enhancer	Fetal Stomach	stomach
40	chr21:44820000-44822400	Enhancers	Primary T helper cells fromperipheralblood	blood
41	chr21:44820000-44822600	Enhancers	Primary T killer memory cells from peripheral blood	blood
42	chr21:44820000-44822800	Enhancers	Fetal Thymus	thymus
43	chr21:44820000-44823200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
44	chr21:44820000-44823600	Enhancers	Skeletal Muscle Female	skeletal muscle
45	chr21:44820200-44821600	Enhancers	Ovary	ovary
46	chr21:44820200-44821800	Enhancers	Sigmoid Colon	Sigmoid Colon
47	chr21:44820200-44821800	Enhancers	Hela-S3	cervix
48	chr21:44820200-44822400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
49	chr21:44820200-44822400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
50	chr21:44820200-44823000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links